HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 107 filers reported holding HOMOLOGY MEDICINES INC in Q1 2022. The put-call ratio across all filers is 4.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43,238 | +32.2% | 36,955 | 0.0% | 0.01% | +28.6% |
| Q2 2023 | $32,706 | -29.8% | 36,955 | 0.0% | 0.01% | -30.0% |
| Q1 2023 | $46,564 | +0.0% | 36,955 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $46,563 | -21.1% | 36,955 | 0.0% | 0.01% | -28.6% |
| Q3 2022 | $59,000 | -19.2% | 36,955 | 0.0% | 0.01% | -17.6% |
| Q2 2022 | $73,000 | -34.8% | 36,955 | 0.0% | 0.02% | -32.0% |
| Q1 2022 | $112,000 | -17.0% | 36,955 | 0.0% | 0.02% | -16.7% |
| Q4 2021 | $135,000 | -53.6% | 36,955 | 0.0% | 0.03% | -53.8% |
| Q3 2021 | $291,000 | +8.2% | 36,955 | 0.0% | 0.06% | +4.8% |
| Q2 2021 | $269,000 | -22.7% | 36,955 | 0.0% | 0.06% | -34.0% |
| Q1 2021 | $348,000 | -16.5% | 36,955 | 0.0% | 0.09% | -26.0% |
| Q4 2020 | $417,000 | +5.6% | 36,955 | 0.0% | 0.13% | -4.5% |
| Q3 2020 | $395,000 | -16.5% | 36,955 | +18.7% | 0.13% | -19.9% |
| Q2 2020 | $473,000 | +0.9% | 31,136 | +3.1% | 0.17% | -7.8% |
| Q1 2020 | $469,000 | – | 30,198 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 4,535,919 | $5,307,025 | 1.53% |
| Western Standard LLC | 250,060 | $292,570 | 0.26% |
| OUP Management Co., LLC | 64,000 | $74,880 | 0.17% |
| Vivo Capital, LLC | 370,068 | $432,980 | 0.05% |
| Temasek Holdings (Private) Ltd | 5,650,996 | $6,611,665 | 0.04% |
| GEORGE KAISER FAMILY FOUNDATION | 39,320 | $46,004 | 0.01% |
| American Investment Services, Inc. | 36,955 | $43,238 | 0.01% |
| RBF Capital, LLC | 58,700 | $68,679 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 185,100 | $216,567 | 0.01% |
| XTX Topco Ltd | 21,188 | $24,790 | 0.00% |